Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you downgrade to Basic or cancel with-in 10 days of first subscribing, we will refund your payment upon request. Immediately after downgrading or cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

BioSyent Inc. (V:RX)

Business Focus: Pharmaceuticals

INK Edge Outlook

Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for RX within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 22, 2019 16:01 ET
BioSyent Announces Notice of Deficiency for Cardiovascular Products
BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that it has been informed by Health Canada that the Company will receive a Notice of Deficiency (“NOD”) with respect to its New Drug Submissions of two cardiovascular products for...
Read full article
Mar 20, 2019 08:00 ET
BioSyent Releases Results for Fourth Quarter and Full Year 2018
BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2018. Key highlights include: Fourth quarter (Q4) 2018 Net Revenues of $5,910,965 increased by 0.2%...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.16
--
--
Price to Sales - TTM
5.04
11.77
19.21
Price to Book - most recent quarter
3.98
2.91
3.45
Price to Cash Flow per share - TTM
18.41
9.90
11.72
Price to Free Cash Flow per share - TTM
17.44
11.95
14.63
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 31, 20195,6083,572
Mar 15, 20192,036-20,144
Feb 28, 201922,18017,980
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc., acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has four business units: the Community and Women's Health Unit, which commercializes pharmaceutical products focused on improving family and women's health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. Cathejell is indicated for surface anesthesia and lubrication for various procedures. RepaGyn helps relieve dryness and promotes healing of the vaginal mucosa. It also manufactures and markets Protect-It, a non-toxic product.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).
INK Staff's picture
Concerns that First Nations being exploited by professional pipeline protestors https://www.canadianinsider.com/blog/muir-concerned-first-nations-being-exploited-professional-pipeline-protestors #Cdnpoli #ABLeg $ECA $ARX.CA
Jan 10, 2019 09:50 am
INK Staff's picture
The INK Canadian Insider Index ends at 1,305.40 +5.79 (+0.45%) as $VRX.CA jumps 7.5% https://www.canadianinsider.com/node/7?menu_tickersearch=vrx #INKCIN $HII.CA
Jun 06, 2018 04:22 pm
INK Staff's picture
The INK Canadian Insider Index ends at 1,299.61 +8.64 (+0.67%) as $VRX.CA rallies 7.6% https://www.canadianinsider.com/node/7?menu_tickersearch=vrx #INKCIN $HII.CA $VRX
Jun 05, 2018 03:51 pm
Ted Dixon's picture
Insiders are selling pot-pharma like $WEED.CA https://www.canadianinsider.com/company?ticker=WEED and buying old skool like $VRX.CA $VRX https://www.canadianinsider.com/company?ticker=vrx
Jan 08, 2018 02:56 pm
INK Staff's picture
Valeant Pharma Insiders bet on better days ahead https://www.canadianinsider.com/featured-report/valeant-pharma-insiders-bet-better-days-ahead $VRX.CA $VRX $TSX.CA
Jun 29, 2017 09:31 am

Twitter

Search (past week) for $RX.CA RX.V

  • No tweets found

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).
INK Staff's picture
Concerns that First Nations being exploited by professional pipeline protestors https://www.canadianinsider.com/blog/muir-concerned-first-nations-being-exploited-professional-pipeline-protestors #Cdnpoli #ABLeg $ECA $ARX.CA
Jan 10, 2019 09:50 am
INK Staff's picture
The INK Canadian Insider Index ends at 1,305.40 +5.79 (+0.45%) as $VRX.CA jumps 7.5% https://www.canadianinsider.com/node/7?menu_tickersearch=vrx #INKCIN $HII.CA
Jun 06, 2018 04:22 pm
INK Staff's picture
The INK Canadian Insider Index ends at 1,299.61 +8.64 (+0.67%) as $VRX.CA rallies 7.6% https://www.canadianinsider.com/node/7?menu_tickersearch=vrx #INKCIN $HII.CA $VRX
Jun 05, 2018 03:51 pm
Ted Dixon's picture
Insiders are selling pot-pharma like $WEED.CA https://www.canadianinsider.com/company?ticker=WEED and buying old skool like $VRX.CA $VRX https://www.canadianinsider.com/company?ticker=vrx
Jan 08, 2018 02:56 pm
INK Staff's picture
Valeant Pharma Insiders bet on better days ahead https://www.canadianinsider.com/featured-report/valeant-pharma-insiders-bet-better-days-ahead $VRX.CA $VRX $TSX.CA
Jun 29, 2017 09:31 am

Twitter

Search (past week) for $RX.CA RX.V

  • No tweets found